- Home
- GCO vs LRMR Comparison
GCO vs LRMR Comparison
Compare GCO & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCO
- LRMR
- Stock Information
- Founded
- GCO 1924
- LRMR N/A
- Country
- GCO United States
- LRMR United States
- Employees
- GCO N/A
- LRMR N/A
- Industry
- GCO Clothing/Shoe/Accessory Stores
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- GCO Consumer Discretionary
- LRMR Health Care
- Exchange
- GCO Nasdaq
- LRMR Nasdaq
- Market Cap
- GCO 452.3M
- LRMR 426.9M
- IPO Year
- GCO N/A
- LRMR N/A
- Fundamental
- Price
- GCO $37.58
- LRMR $3.19
- Analyst Decision
- GCO Hold
- LRMR Strong Buy
- Analyst Count
- GCO 1
- LRMR 9
- Target Price
- GCO $31.00
- LRMR $19.44
- AVG Volume (30 Days)
- GCO 201.4K
- LRMR 630.8K
- Earning Date
- GCO 03-07-2025
- LRMR 03-13-2025
- Dividend Yield
- GCO N/A
- LRMR N/A
- EPS Growth
- GCO N/A
- LRMR N/A
- EPS
- GCO N/A
- LRMR N/A
- Revenue
- GCO $2,318,063,000.00
- LRMR N/A
- Revenue This Year
- GCO $2.51
- LRMR N/A
- Revenue Next Year
- GCO $2.06
- LRMR N/A
- P/E Ratio
- GCO N/A
- LRMR N/A
- Revenue Growth
- GCO 0.32
- LRMR N/A
- 52 Week Low
- GCO $23.21
- LRMR $3.01
- 52 Week High
- GCO $44.80
- LRMR $12.91
- Technical
- Relative Strength Index (RSI)
- GCO 39.01
- LRMR 37.56
- Support Level
- GCO $37.25
- LRMR $3.06
- Resistance Level
- GCO $41.52
- LRMR $3.52
- Average True Range (ATR)
- GCO 1.71
- LRMR 0.22
- MACD
- GCO -0.29
- LRMR 0.02
- Stochastic Oscillator
- GCO 12.09
- LRMR 15.66
About GCO Genesco Inc.
Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz, and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group is comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group is comprised of Johnston & Murphy retail operations, e-commerce operations, and catalog and wholesale distribution of products under the Johnston & Murphy and Genesco Brands Group. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.